GLA and Fabry disease: Treatment of FD is based on two main options: enzyme replacement therapy (ERT), agalsidase alfa and beta, administered intravenously every 14 days, and chaperone therapy (migalastat), taken orally every other day [1,2], which is only indicated for patients with FD caused by specific genetic variants defined as “amenable”.